SkinHealth Systems Inc.
10.88USD
-0.2150 (-1.94%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SKIN.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 72 | 65 | 82 | 71 | 78 | 70 | 83 | 79 |
| Cost of Revenue | 23 | 20 | 29 | 25 | 29 | 21 | 31 | 38 |
| Gross Profit | 49 | 44 | 53 | 46 | 49 | 49 | 52 | 41 |
| Operating Income | 4 | -2 | 0 | -6 | -3 | -12 | -7 | -22 |
| Net Income | -3 | -7 | -8 | -11 | 20 | -10 | -10 | -18 |
| EPS (Diluted) | -$0.02 | -$0.05 | -$0.05 | -$0.09 | $0.03 | -$0.08 | -$0.05 | -$0.15 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)